SOPHiA Genetics SA 

$5.35
12
+$0.1+1.9% Monday 21:00

Statistics

Day High
5.62
Day Low
5.23
52W High
5.7
52W Low
2.58
Volume
838,479
Avg. Volume
156,629
Mkt Cap
361.55M
P/E Ratio
-
Dividend Yield
-
Dividend
-

Upcoming

Earnings

3MarExpected
Q2 2024
Q3 2024
Q4 2024
Q1 2025
Q2 2025
Q3 2025
Next
-0.33
-0.29
-0.25
-0.21
Expected EPS
-0.2375
Actual EPS
N/A

Financials

-95.89%Profit Margin
Unprofitable
2020
2021
2022
2023
2024
130.35MRevenue
-124.99MNet Income

Analyst Ratings

$7.00Average Price Target
The highest estimate is 7.00.
From 2 ratings within the last 6 months. This is not an investment recommendation.
Buy
100%
Hold
0%
Sell
0%

People Also Follow

This list is based on the watchlists of people on Stock Events who follow SOPH. It's not an investment recommendation.

Competitors

This list is an analysis based on recent market events. It's not an investment recommendation.
Illumina
ILMN
Mkt Cap18.99B
Illumina provides sequencing and array-based solutions for genetic analysis, directly competing in the genomics space with SOPHiA Genetics' data-driven analysis.
Pacific Biosciences of California
PACB
Mkt Cap702.87M
Pacific Biosciences offers long-read sequencing technologies that compete with SOPHiA Genetics in the genomic analysis and clinical diagnostics market.
Guardant Health
GH
Mkt Cap11.72B
Guardant Health specializes in liquid biopsies and cancer diagnostics, competing with SOPHiA Genetics in the oncology diagnostics market.
Fulgent Genetics
FLGT
Mkt Cap687.17M
Fulgent Genetics offers comprehensive genetic testing and competes with SOPHiA Genetics in the genetic analysis and diagnostics market.
Qiagen NV
QGEN
Mkt Cap10.16B
Bionano Genomics
BNGO
Mkt Cap17.42M
Bionano Genomics focuses on genomic analysis with its Saphyr system, competing in the structural variation analysis market alongside SOPHiA Genetics.
Exact Sciences
EXAS
Mkt Cap12.25B
Exact Sciences specializes in cancer diagnostics, including molecular screening tests, competing with SOPHiA Genetics in the molecular diagnostics market.
Thermo Fisher Scientific
TMO
Mkt Cap214.25B
Thermo Fisher Scientific offers a wide range of solutions for genetic analysis and diagnostics, making it a broad competitor to SOPHiA Genetics in the life sciences sector.
Intellia Therapeutics
NTLA
Mkt Cap1.35B
Intellia Therapeutics is involved in CRISPR gene editing, a technology that could compete with SOPHiA Genetics in the future of genetic diagnostics and therapeutics.

About

SOPHiA GENETICS SA operates as a healthcare technology company. The company offers SOPHiA DDM platform, a cloud-based software-as-a-service platform for analyzing data and generating insights from multimodal data sets and diagnostic modalities. Its SOPHiA DDM platform and related solutions, products, and services are used by hospital, laboratory, and biopharma worldwide. SOPHiA GENETICS SA was incorporated in 2011 and is headquartered in Saint-Sulpice, Switzerland.
Show more...
CEO
Dr. Jurgi Camblong M.B.A., Ph.D.
Employees
423
Country
CH
ISIN
CH1125843347

Listings

0 Comments

Share your thoughts

FAQ

What is SOPHiA Genetics SA stock price today?
The current price of SOPH is $5.35 USD — it has increased by +1.9% in the past 24 hours. Watch SOPHiA Genetics SA stock price performance more closely on the chart.
What is SOPHiA Genetics SA stock ticker?
Depending on the exchange, the stock ticker may vary. For instance, on exchange SOPHiA Genetics SA stocks are traded under the ticker SOPH.
Is SOPHiA Genetics SA stock price growing?
SOPH stock has risen by +1.9% compared to the previous week, the month change is a +14.56% rise, over the last year SOPHiA Genetics SA has showed a +51.56% increase.
What is SOPHiA Genetics SA market cap?
Today SOPHiA Genetics SA has the market capitalization of 361.55M
When is the next SOPHiA Genetics SA earnings date?
SOPHiA Genetics SA is going to release the next earnings report on March 03, 2026.
What were SOPHiA Genetics SA earnings last quarter?
SOPH earnings for the last quarter are -0.3 USD per share, whereas the estimation was -0.23 USD resulting in a -30.43% surprise. The estimated earnings for the next quarter are N/A USD per share.
What is SOPHiA Genetics SA revenue for the last year?
SOPHiA Genetics SA revenue for the last year amounts to 130.35M USD.
What is SOPHiA Genetics SA net income for the last year?
SOPH net income for the last year is -124.99M USD.
How many employees does SOPHiA Genetics SA have?
As of February 03, 2026, the company has 423 employees.
In which sector is SOPHiA Genetics SA located?
SOPHiA Genetics SA operates in the Health Care sector.
When did SOPHiA Genetics SA complete a stock split?
SOPHiA Genetics SA has not had any recent stock splits.
Where is SOPHiA Genetics SA headquartered?
SOPHiA Genetics SA is headquartered in Rolle, CH.